OptimizeRx Corporation (OPRX)
USD 7.32
(-5.61%)
USD 7.32
(-5.61%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -17.56 Million USD | -65.93% |
| 2022 | -10.58 Million USD | -3964.56% |
| 2021 | 273.92 Thousand USD | 111.49% |
| 2020 | -2.38 Million USD | 24.15% |
| 2019 | -3.14 Million USD | -1488.41% |
| 2018 | 226.34 Thousand USD | 110.76% |
| 2017 | -2.1 Million USD | -36.7% |
| 2016 | -1.53 Million USD | -158.63% |
| 2015 | -595.14 Thousand USD | 41.96% |
| 2014 | -1.02 Million USD | -575.06% |
| 2013 | 215.84 Thousand USD | 159.3% |
| 2012 | -363.97 Thousand USD | 82.84% |
| 2011 | -2.12 Million USD | -5.56% |
| 2010 | -2 Million USD | 55.9% |
| 2009 | -4.55 Million USD | -7.22% |
| 2008 | -4.24 Million USD | -1075.45% |
| 2007 | -361.46 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -6.89 Million USD | -66.59% |
| 2024 Q2 | -4 Million USD | 41.9% |
| 2023 FY | -17.56 Million USD | -65.93% |
| 2023 Q3 | -2.86 Million USD | 31.15% |
| 2023 Q4 | -4.14 Million USD | -44.54% |
| 2023 Q1 | -6.39 Million USD | -3108.2% |
| 2023 Q2 | -4.16 Million USD | 34.95% |
| 2022 Q1 | -3.76 Million USD | -703.26% |
| 2022 Q4 | 212.67 Thousand USD | 106.69% |
| 2022 FY | -10.58 Million USD | -3964.56% |
| 2022 Q2 | -3.86 Million USD | -2.65% |
| 2022 Q3 | -3.17 Million USD | 17.72% |
| 2021 Q1 | -637.37 Thousand USD | -146.96% |
| 2021 FY | 273.92 Thousand USD | 111.49% |
| 2021 Q2 | 352.1 Thousand USD | 155.24% |
| 2021 Q3 | 39.89 Thousand USD | -88.67% |
| 2021 Q4 | 623.46 Thousand USD | 1462.8% |
| 2020 Q1 | -2.2 Million USD | -11.04% |
| 2020 FY | -2.38 Million USD | 24.15% |
| 2020 Q3 | -282.89 Thousand USD | 73.74% |
| 2020 Q2 | -1.07 Million USD | 51.11% |
| 2020 Q4 | 1.35 Million USD | 579.74% |
| 2019 Q3 | -1.57 Million USD | -486.34% |
| 2019 FY | -3.14 Million USD | -1488.41% |
| 2019 Q1 | 6529.00 USD | 105.94% |
| 2019 Q4 | -1.98 Million USD | -26.34% |
| 2019 Q2 | 406.61 Thousand USD | 6127.86% |
| 2018 Q4 | -109.91 Thousand USD | -144.88% |
| 2018 FY | 226.34 Thousand USD | 110.76% |
| 2018 Q3 | 244.92 Thousand USD | -12.68% |
| 2018 Q2 | 280.5 Thousand USD | 248.28% |
| 2018 Q1 | -189.17 Thousand USD | 20.2% |
| 2017 Q3 | -622.78 Thousand USD | -72.28% |
| 2017 Q4 | -237.05 Thousand USD | 61.94% |
| 2017 Q1 | -882.68 Thousand USD | -150.23% |
| 2017 Q2 | -361.5 Thousand USD | 59.05% |
| 2017 FY | -2.1 Million USD | -36.7% |
| 2016 Q1 | -351.91 Thousand USD | 15.13% |
| 2016 Q3 | -242.58 Thousand USD | 59.02% |
| 2016 Q2 | -591.93 Thousand USD | -68.2% |
| 2016 Q4 | -352.75 Thousand USD | -45.41% |
| 2016 FY | -1.53 Million USD | -158.63% |
| 2015 Q2 | -157.22 Thousand USD | -41.39% |
| 2015 Q4 | -414.65 Thousand USD | -571.53% |
| 2015 Q3 | 87.93 Thousand USD | 155.93% |
| 2015 FY | -595.14 Thousand USD | 41.96% |
| 2015 Q1 | -111.2 Thousand USD | -248.43% |
| 2014 Q3 | -394.31 Thousand USD | -648.49% |
| 2014 Q4 | 74.91 Thousand USD | 119.0% |
| 2014 FY | -1.02 Million USD | -575.06% |
| 2014 Q1 | -653.31 Thousand USD | -1376.02% |
| 2014 Q2 | -52.68 Thousand USD | 91.94% |
| 2013 FY | 215.84 Thousand USD | 159.3% |
| 2013 Q1 | -104.82 Thousand USD | -188.09% |
| 2013 Q4 | -44.26 Thousand USD | -510.75% |
| 2013 Q2 | 354.15 Thousand USD | 437.85% |
| 2013 Q3 | 10.77 Thousand USD | -96.96% |
| 2012 Q2 | -76.05 Thousand USD | 74.71% |
| 2012 Q1 | -300.73 Thousand USD | 40.3% |
| 2012 FY | -363.97 Thousand USD | 82.84% |
| 2012 Q4 | 118.99 Thousand USD | 212.07% |
| 2012 Q3 | -106.17 Thousand USD | -39.59% |
| 2011 Q3 | -969.37 Thousand USD | -124.04% |
| 2011 Q1 | -214.93 Thousand USD | 41.69% |
| 2011 Q2 | -432.68 Thousand USD | -101.31% |
| 2011 Q4 | -503.76 Thousand USD | 48.03% |
| 2011 FY | -2.12 Million USD | -5.56% |
| 2010 Q1 | -260.96 Thousand USD | 88.8% |
| 2010 Q3 | -504.57 Thousand USD | 42.33% |
| 2010 FY | -2 Million USD | 55.9% |
| 2010 Q2 | -874.9 Thousand USD | -235.25% |
| 2010 Q4 | -368.57 Thousand USD | 26.95% |
| 2009 Q4 | -2.33 Million USD | -346.3% |
| 2009 FY | -4.55 Million USD | -7.22% |
| 2009 Q3 | -522.2 Thousand USD | -52.63% |
| 2009 Q2 | -342.14 Thousand USD | 74.86% |
| 2009 Q1 | -1.36 Million USD | 59.33% |
| 2008 Q1 | -548.48 Thousand USD | 0.0% |
| 2008 Q3 | -161.4 Thousand USD | 69.84% |
| 2008 Q2 | -535.23 Thousand USD | 2.42% |
| 2008 FY | -4.24 Million USD | -1075.45% |
| 2008 Q4 | -3.34 Million USD | -1972.94% |
| 2007 FY | -361.46 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CareCloud, Inc. | -48.67 Million USD | 63.911% |
| Augmedix, Inc. | -19.17 Million USD | 8.373% |
| BrightSpring Health Services, Inc. Common Stock | -154.6 Million USD | 88.638% |
| CareCloud, Inc. | -48.67 Million USD | 63.911% |
| HealthEquity, Inc. | 55.71 Million USD | 131.53% |
| iCoreConnect Inc. | -15.55 Million USD | -12.952% |
| Inovalon Holdings, Inc. | 22.57 Million USD | 177.797% |
| Nutex Health, Inc. | -45.78 Million USD | 61.635% |
| Omnicell, Inc. | -20.37 Million USD | 13.77% |
| OneMedNet Corporation | -23.2 Million USD | 24.303% |
| Progyny, Inc. | 62.03 Million USD | 128.315% |
| Renalytix Plc | -33.45 Million USD | 47.496% |
| Schrödinger, Inc. | 40.72 Million USD | 143.138% |
| Simulations Plus, Inc. | 9.95 Million USD | 276.47% |
| SOPHiA GENETICS SA | -78.98 Million USD | 77.759% |
| Streamline Health Solutions, Inc. | -18.69 Million USD | 6.05% |
| Ontrak, Inc. | -27.92 Million USD | 37.085% |
| GE HealthCare Technologies Inc. | 1.56 Billion USD | 101.12% |
| Sharecare, Inc. | -128.49 Million USD | 86.33% |
| Aclarion, Inc. | -4.91 Million USD | -257.657% |
| CareMax, Inc. | -683.34 Million USD | 97.429% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.35 Million USD | -227.974% |
| Forian Inc. | 11.1 Million USD | 258.156% |
| Bullfrog AI Holdings, Inc. Warrants | -5.35 Million USD | -227.974% |
| HeartBeam, Inc. | -14.63 Million USD | -19.994% |
| GeneDx Holdings Corp. | -175.76 Million USD | 90.006% |
| SCWorx Corp. | -3.98 Million USD | -341.227% |
| Minerva Surgical, Inc. | -34.11 Million USD | 48.505% |
| Definitive Healthcare Corp. | -202.38 Million USD | 91.321% |
| 10x Genomics, Inc. | -255.09 Million USD | 93.114% |
| Zhongchao Inc. | -11.33 Million USD | -54.958% |
| Accolade, Inc. | -99.8 Million USD | 82.4% |
| MSP Recovery, Inc. | -56.34 Million USD | 68.826% |
| R1 RCM Inc. | 3.3 Million USD | 632.299% |
| Spok Holdings, Inc. | 15.66 Million USD | 212.127% |
| Privia Health Group, Inc. | 23.07 Million USD | 176.112% |
| EUDA Health Holdings Limited | -10.03 Million USD | -74.968% |
| TruBridge, Inc. | -45.78 Million USD | 61.637% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | -154.6 Million USD | 88.638% |
| Sharecare, Inc. | -128.49 Million USD | 86.33% |
| Health Catalyst, Inc. | -118.14 Million USD | 85.132% |
| GoodRx Holdings, Inc. | -8.86 Million USD | -98.081% |
| Premier, Inc. | 119.54 Million USD | 114.694% |
| HealthStream, Inc. | 15.21 Million USD | 215.466% |
| Certara, Inc. | -55.35 Million USD | 68.268% |
| GeneDx Holdings Corp. | -175.76 Million USD | 90.006% |
| Ontrak, Inc. | -27.92 Million USD | 37.085% |
| SHL Telemedicine Ltd. | -7.05 Million USD | -148.949% |
| CareCloud, Inc. | -48.67 Million USD | 63.911% |
| EUDA Health Holdings Limited | -10.03 Million USD | -74.968% |
| HeartBeam, Inc. | -14.63 Million USD | -19.994% |
| Mangoceuticals, Inc. | -9.21 Million USD | -90.676% |
| CareMax, Inc. | -683.34 Million USD | 97.429% |
| Healthcare Triangle, Inc. | -12.33 Million USD | -42.361% |
| National Research Corporation | 30.97 Million USD | 156.717% |
| Aclarion, Inc. | -4.91 Million USD | -257.657% |